Insiders · KYTX

KYTX insider transactions

Kyverna Therapeutics Inc. (KYTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KYTX

• 40d
  Chief Financial Officer Grasso Marc was granted 10,000 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 40d
  Chief Executive Officer Biddle Warner Weston was granted 58,000 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 40d
  Officer Gehchan Naji was granted 18,000 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 53d
  SEC Form 3 filed by new insider Miller Andrew Craig

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 53d
  Director Miller Andrew Craig was granted 11,006 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 59d
  SEC Form 3 filed by new insider Emany Sravan Kumar

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 59d
  Director Emany Sravan Kumar was granted 11,006 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 74d
  SEC Form 3 filed by new insider Pujols Mayobanex

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 74d
  SEC Form 4 filed by Chief Technology Officer Pujols Mayobanex

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 102d
  Executive Chairperson Shaw Christi was granted 54,301 shares, increasing direct ownership by 326% to 70,935 units (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 125d
  Director Seidenberg Beth C bought $999,998 worth of shares (133,333 units at $7.50) (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 125d
  Large owner Westlake Biopartners Opportunity Fund I, L.P. bought $999,998 worth of shares (133,333 units at $7.50) (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 129d
  Chief Technology Officer Walker Karen Marie exercised 23,998 shares at a strike of $4.83 and sold $292,776 worth of shares (23,998 units at $12.20) (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 298d
  SEC Form 4 filed by Chief Financial Officer Grasso Marc

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 298d
  SEC Form 3 filed by new insider Grasso Marc

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Shaw Christi was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Seidenberg Beth C was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Spiegelman Daniel K was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Aktar Mert was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Clark Ian T was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 328d
  Director Cohen Fred E was granted 16,634 shares (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 376d
  SEC Form 4 filed by Chief Executive Officer Biddle Warner Weston

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 376d
  Chief Financial Officer Jones Ryan Alexander was granted 12,000 shares, increasing direct ownership by 27% to 55,950 units (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 376d
  Chief Technology Officer Walker Karen Marie was granted 13,000 shares, increasing direct ownership by 135% to 22,636 units (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 431d
  SEC Form 4 filed by Director Shaw Christi

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 456d
  SEC Form 4 filed by Officer Gehchan Naji

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 456d
  SEC Form 3 filed by new insider Gehchan Naji

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 549d
  SEC Form 4 filed by Director Aktar Mert

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 549d
  SEC Form 3 filed by new insider Aktar Mert

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 584d
  SEC Form 4 filed by Chief Executive Officer Biddle Warner Weston

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 584d
  SEC Form 4 filed by Director Shaw Christi

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 584d
  SEC Form 3 filed by new insider Biddle Warner Weston

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 584d
  SEC Form 3 filed by new insider Shaw Christi

  3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 685d
  Chief Technology Officer Walker Karen Marie exercised 9,636 shares at a strike of $4.42 (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)
• 697d
  Jones Ryan Alexander exercised 18,016 shares at a strike of $0.73, increasing direct ownership by 69% to 43,950 units (SEC Form 4)

  4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)